The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings

Although there were promising updates from some coronavirus vaccine makers, negative headlines plagued Novavax, Inc. and Moderna Inc., sending their stocks lower by 4.7% and 23%, respectively, for the week.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.